Literature DB >> 21918970

Differential role for CD277 as a co-regulator of the immune signal in T and NK cells.

Nassima Messal1, Emilie Mamessier, Aude Sylvain, Javier Celis-Gutierrez, Marie-Laure Thibult, Bruno Chetaille, Guylène Firaguay, Sonia Pastor, Yves Guillaume, Qian Wang, Ivan Hirsch, Jacques A Nunès, Daniel Olive.   

Abstract

The human butyrophilin (BTN) 3 or CD277 molecules belong to the B7 family members and are expressed in various immune cells such as T and NK cells. Here, we show that CD277 triggering considerably enhances TCR-induced cytokine production and cell proliferation, even when another co-stimulatory molecule, CD28, is engaged. These CD277-induced additive functional effects are in accordance with the detection of early T-cell activation events such as TCR-induced cell signaling being increased upon CD277 engagement. However, we found that CD277 triggering is not involved in CD16- or NKp46-induced NK cell activation. BTN3/CD277 comprises three structurally related members, BTN3A1, BTN3A2 and BTN3A3. CD277 antibodies recognize all isoforms and we describe a differential expression of BTN3 isoforms between T and NK cells that could explain differential CD277 functions between T and NK cells. Our results show that, while T cells express all BTN3/CD277 transcripts, NK cells express mostly BTN3A2, which lacks the B30.2 intracellular domain. Furthermore, NKp30-induced cytokine production is decreased by the specific engagement of BTN3A2, but not by BTN3A1 triggering. Thus, we provide new insights into the CD277 co-stimulatory pathway that may differentially participate in the regulation of various cell-mediated immune responses.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918970     DOI: 10.1002/eji.201141404

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

1.  Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells.

Authors:  Dieter Kabelitz
Journal:  Cell Mol Immunol       Date:  2013-10-07       Impact factor: 11.530

2.  HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors.

Authors:  Ashley M Kilcollins; Jin Li; Chia-Hung Christine Hsiao; Andrew J Wiemer
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

Review 3.  The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response.

Authors:  Hassnae Afrache; Philippe Gouret; Shanaiz Ainouche; Pierre Pontarotti; Daniel Olive
Journal:  Immunogenetics       Date:  2012-09-23       Impact factor: 2.846

Review 4.  Immune modulation by butyrophilins.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

5.  BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.

Authors:  Audrey Benyamine; Aude Le Roy; Emilie Mamessier; Julie Gertner-Dardenne; Céline Castanier; Florence Orlanducci; Laurent Pouyet; Armelle Goubard; Yves Collette; Norbert Vey; Emmanuel Scotet; Remy Castellano; Daniel Olive
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

6.  BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.

Authors:  Kyle K Payne; Jessica A Mine; Subir Biswas; Ricardo A Chaurio; Alfredo Perales-Puchalt; Carmen M Anadon; Tara Lee Costich; Carly M Harro; Jennifer Walrath; Qianqian Ming; Evgenii Tcyganov; Andrea L Buras; Kristen E Rigolizzo; Gunjan Mandal; Jason Lajoie; Michael Ophir; Julia Tchou; Douglas Marchion; Vincent C Luca; Piotr Bobrowicz; Brooke McLaughlin; Ugur Eskiocak; Michael Schmidt; Juan R Cubillos-Ruiz; Paulo C Rodriguez; Dmitry I Gabrilovich; Jose R Conejo-Garcia
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

7.  BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Audrey Benyamine; Céline Loncle; Etienne Foucher; Juan-Luis Blazquez; Céline Castanier; Anne-Sophie Chrétien; Mauro Modesti; Véronique Secq; Salem Chouaib; Meritxell Gironella; Elena Vila-Navarro; Giuseppe Montalto; Jean-Charles Dagorn; Nelson Dusetti; Juan Iovanna; Daniel Olive
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

8.  Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection.

Authors:  J Ampuero; J A del Campo; L Rojas; R J García-Lozano; M Buti; R Solá; X Forns; R Moreno-Otero; R Andrade; M Diago; J Salmerón; L Rodrigo; J A Pons; J M Navarro; J L Calleja; J García-Samaniego; M García-Valdecasas; Á Rojas; R Millán; M F González-Escribano; M Romero-Gómez
Journal:  Genes Immun       Date:  2015-04-30       Impact factor: 2.676

Review 9.  The role of B7 family molecules in hematologic malignancy.

Authors:  Paul Greaves; John G Gribben
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

10.  Dok1 and Dok2 proteins regulate natural killer cell development and function.

Authors:  Javier Celis-Gutierrez; Marilyn Boyron; Thierry Walzer; Pier Paolo Pandolfi; Stipan Jonjić; Daniel Olive; Marc Dalod; Eric Vivier; Jacques A Nunès
Journal:  EMBO J       Date:  2014-06-24       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.